MetLife Investment Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,989
| Closed | -$73.6K | – | 2828 |
|
|
2023
Q3 | $73.6K | Hold |
1,989
| – | – | ﹤0.01% | 2738 |
|
|
2023
Q2 | $80.1K | Hold |
1,989
| – | – | ﹤0.01% | 2805 |
|
|
2023
Q1 | $144K | Buy |
1,989
+546
| +38% | +$39.6K | ﹤0.01% | 2395 |
|
|
2022
Q4 | $118K | Sell |
1,443
-449
| -24% | -$36.8K | ﹤0.01% | 2517 |
|
|
2022
Q3 | $179K | Buy |
1,892
+208
| +12% | +$19.7K | ﹤0.01% | 2367 |
|
|
2022
Q2 | $328K | Sell |
1,684
-183
| -10% | -$35.6K | ﹤0.01% | 1957 |
|
|
2022
Q1 | $434K | Buy |
1,867
+677
| +57% | +$157K | ﹤0.01% | 1856 |
|
|
2021
Q4 | $469K | Hold |
1,190
| – | – | ﹤0.01% | 1542 |
|
|
2021
Q3 | $533K | Hold |
1,190
| – | – | ﹤0.01% | 1485 |
|
|
2021
Q2 | $463K | Hold |
1,190
| – | – | ﹤0.01% | 1613 |
|
|
2021
Q1 | $427K | Hold |
1,190
| – | – | ﹤0.01% | 1623 |
|
|
2020
Q4 | $584K | Hold |
1,190
| – | – | 0.01% | 1410 |
|
|
2020
Q3 | $386K | Hold |
1,190
| – | – | ﹤0.01% | 1506 |
|
|
2020
Q2 | $434K | Buy |
1,190
+239
| +25% | +$87.1K | ﹤0.01% | 1461 |
|
|
2020
Q1 | $202K | Hold |
951
| – | – | ﹤0.01% | 1692 |
|
|
2019
Q4 | $392K | Hold |
951
| – | – | ﹤0.01% | 1596 |
|
|
2019
Q3 | $336K | Buy |
951
+198
| +26% | +$69.9K | ﹤0.01% | 1633 |
|
|
2019
Q2 | $379K | Hold |
753
| – | – | ﹤0.01% | 1647 |
|
|
2019
Q1 | $749K | Hold |
753
| – | – | 0.01% | 1213 |
|
|
2018
Q4 | $654K | Hold |
753
| – | – | 0.01% | 1208 |
|
|
2018
Q3 | $779K | Hold |
753
| – | – | 0.01% | 1261 |
|
|
2018
Q2 | $692K | Buy |
753
+151
| +25% | +$139K | 0.01% | 1210 |
|
|
2018
Q1 | $587K | Buy |
602
+123
| +26% | +$120K | 0.01% | 1278 |
|
|
2017
Q4 | $217K | Buy |
+479
| New | +$217K | ﹤0.01% | 1882 |
|